Cargando…

Onset of Remission Following COVID-19 Infection in a Patient with Refractory Lupus Nephritis

Detalles Bibliográficos
Autor principal:	Sathiavageesan, Subrahmanian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2022
Materias:	Letter To Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9365004/ https://www.ncbi.nlm.nih.gov/pubmed/35967534 http://dx.doi.org/10.4103/ijn.ijn_375_21

Ejemplares similares

Right Renal Biopsy Through Petit's triangle
por: Sathiavageesan, Subrahmanian
Publicado: (2020)

New-onset systemic lupus erythematosus beginning as class V lupus nephritis after COVID-19 vaccination
por: Zavala-Miranda, María Fernanda, et al.
Publicado: (2021)

New-onset class III lupus nephritis with multi-organ involvement after COVID-19 vaccination
por: Kim, Hyo Jeong, et al.
Publicado: (2022)

Acquired Protein S Deficiency in a Patient with Lupus Nephritis
por: Meriam, Hajji, et al.
Publicado: (2019)

Relapse of class V lupus nephritis after vaccination with COVID-19 mRNA vaccine
por: Tuschen, Katharina, et al.
Publicado: (2021)

Secukinumab on Refractory Lupus Nephritis
por: Costa, Rita, et al.
Publicado: (2021)

The LE Cell—A Forgotten Entity
por: Sathiavageesan, Subrahmanian, et al.
Publicado: (2021)

Complete Remission of Lupus Nephritis Following Chemoradiotherapy of Carcinoma Cervix: An Association
por: Girimaji, Niveditha, et al.
Publicado: (2021)

Comparison of renal remission and relapse‐free rate in initial‐ and delayed‐onset lupus nephritis
por: Suzuki, Eiji, et al.
Publicado: (2021)

Eculizumab as rescue therapy in severe resistant lupus nephritis
por: Pickering, Matthew C., et al.
Publicado: (2015)

New-onset of juvenile systemic lupus erythematosus following COVID-19 vaccination: First case report
por: de Carvalho, Jozélio Freire
Publicado: (2023)

Experience with abatacept in refractory lupus nephritis
por: Calatayud, Emma, et al.
Publicado: (2023)

Daratumumab monotherapy for refractory lupus nephritis
por: Roccatello, Dario, et al.
Publicado: (2023)

Early achievement of deep remission predicts low incidence of renal flare in lupus nephritis class III or IV
por: Hanaoka, Hironari, et al.
Publicado: (2018)

Re-biopsy in lupus nephritis: Re-biópsia em nefrite lúpica
por: Husein, Raida, et al.
Publicado: (2014)

Worse Renal Presentation and Prognosis in Initial-Onset Lupus Nephritis than Early-Onset Lupus Nephritis
por: Kwon, Oh Chan, et al.
Publicado: (2020)

Remission of lupus nephritis: the trajectory of histological response in successfully treated patients
por: Malvar, Ana, et al.
Publicado: (2023)

Regulatory B and T Cells and Their Association With Clinical Response in New-Onset Lupus Nephritis Patients
por: Girimaji, Niveditha, et al.
Publicado: (2020)

Bullous systemic lupus erythematosus associated with increased activity of lupus nephritis: a case report and review of the literature
por: Żychowska, Magdalena, et al.
Publicado: (2018)

Therapeutic Implications of Renal Biopsies to Detect Proliferative Lupus Nephritis in Patients With Low-Grade Proteinuria
por: Plüß, Marlene, et al.
Publicado: (2020)

Serum tsRNA as a novel molecular diagnostic biomarker for lupus nephritis
por: Zhang, Xiaoshan, et al.
Publicado: (2022)

Discovery of urine biomarkers for lupus nephritis via quantitative and comparative proteome analysis
por: Kwon, Oh Chan, et al.
Publicado: (2021)

Comment on the Article “Adalimumab-Induced Lupus Nephritis: Case Report and Review of the Literature”
por: Drosos, Alexandros A., et al.
Publicado: (2023)

Management of refractory lupus nephritis: challenges and solutions
por: Yo, JH, et al.
Publicado: (2019)

Molecular remission using three monoclonal antibodies followed by allogeneic bone marrow transplantation in an infant with refractory ALL
por: Gruhn, Bernd, et al.
Publicado: (2020)

Systemic Lupus Erythematosus Following COVID-19 Vaccination
por: Salleh, Anna Farazilah Mohd, et al.
Publicado: (2022)

A case of acute interstitial nephritis following the Pfizer–BioNTech COVID-19 vaccine
por: de la Flor Merino, José Carlos, et al.
Publicado: (2022)

Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
por: Masset, Christophe, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome with spinal cord involvement as the first presentation of lupus nephritis
por: Okhovat, Ali Asghar, et al.
Publicado: (2019)

EP16 Challenges in treating new onset systemic lupus erythematosus with lupus nephritis and COVID-19 infection overlap
por: Dahou, Selma, et al.
Publicado: (2020)

Tubulointerstitial nephritis and uveitis syndrome post‐COVID‐19
por: Maggio, Maria Cristina, et al.
Publicado: (2023)

Onset of blast crisis in chronic myeloid leukemia patients in treatment-free remission
por: Dulucq, Stephanie, et al.
Publicado: (2022)

Immunoadsorption: A New Strategy to Induce Remission in Membranous Lupus Nephritis
por: Ulinski, Tim, et al.
Publicado: (2014)

The Steroids In the Maintenance of remission of Proliferative Lupus nephritis (SIMPL) pilot trial
por: Galbraith, Lauren, et al.
Publicado: (2014)

Cardiovascular risk assessment in lupus nephritis and ANCA-associated vasculitis in real-world nephrology practice
por: Tan, Hui Zhuan, et al.
Publicado: (2022)

Rituximab can Decrease Proteinuria in Refractory Lupus Nephritis
por: Suh, Chang-Hee
Publicado: (2022)

Acute interstitial nephritis following COVID-19 vaccination
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Rituximab Therapy for Refractory Autoimmune Thrombocytopenia in Patients with Systemic Lupus Erythematosus
por: Atay, Didem, et al.
Publicado: (2012)

Immune Cell Landscape Identification Associates Intrarenal Mononuclear Phagocytes With Onset and Remission of Lupus Nephritis in NZB/W Mice
por: Li, Bin, et al.
Publicado: (2020)

Comparison of Two Steroid Regimens in Induction Therapy of Proliferative Lupus Nephritis: A Randomized Controlled Trial
por: Bharati, Joyita, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_932d19e9i2i81e3cgbtj11gvie